Andrew J. Bentall, M.B., Ch.B., M.D.

  1. Nephrologist

Publications

  1. Singh Prince, Bentall Andrew, Erickson SB. CT Scan Surprise in a Potential Kidney Donor Kidney 360. 2020.
  2. El Ters M, Bobart SA, Cornell LD, Leung N, Bentall A, Sethi S, Fidler M, Grande J, Hernandez LH, Cosio FG, Zand L, Amer H, Fervenza FC, Nasr SH, Alexander MP. Recurrence of DNAJB9-Positive Fibrillary Glomerulonephritis After Kidney Transplantation: A Case Series. Am J Kidney Dis. 2020 May 12 [Epub ahead of print]
    View PubMed
  3. Alexander MP, Bentall A, Aleff PCA, Gandhi MJ, Scott JP, Roden AC. Ultrastructural changes in pulmonary allografts with antibody-mediated rejection. J Heart Lung Transplant. 2020 Feb; 39 (2):165-175 Epub 2019 Dec 06
    View PubMed
  4. Kukla A, Hill J, Merzkani M, Bentall A, Lorenz EC, Park WD, D'Costa M, Kudva YC, Stegall MD, Shah P. The Use of GLP1R Agonists for the Treatment of Type 2 Diabetes in Kidney Transplant Recipients. Transplant Direct. 2020 Feb; 6 (2):e524 Epub 2020 Jan 13
    View PubMed
  5. Stegall MD, Smith B, Bentall A, Schinstock C. The need for novel trial designs, master protocols, and research consortia in transplantation. Clin Transplant. 2020 Jan; 34 (1):e13759 Epub 2019 Dec 31
    View PubMed
  6. Schinstock CA, Smith BH, Montgomery RA, Jordan SC, Bentall AJ, Mai M, Khamash HA, Stegall MD. Managing highly sensitized renal transplant candidates in the era of kidney paired donation and the new kidney allocation system: Is there still a role for desensitization? Clin Transplant. 2019 Dec; 33 (12):e13751 Epub 2019 Nov 26
    View PubMed
  7. Tan EK, Bentall A, Dean PG, Shaheen MF, Stegall MD, Schinstock CA. Use of Eculizumab for Active Antibody-mediated Rejection That Occurs Early Post-kidney Transplantation: A Consecutive Series of 15 Cases. Transplantation. 2019 Nov; 103 (11):2397-2404
    View PubMed
  8. Bentall A, Smith BH, Gonzales MM, Bonner K, Park WD, Cornell LD, Dean PG, Schinstock CA, Borrows R, Lefaucheur C, Loupy A, Stegall MD. Modeling graft loss in patients with donor-specific antibody at baseline using the Birmingham-Mayo (BirMay) predictor: Implications for clinical trials. Am J Transplant. 2019 Aug; 19 (8):2274-2283 Epub 2019 Mar 13
    View PubMed
  9. Broecker V, Bardsley V, Torpey N, Perera R, Montero R, Dorling A, Bentall A, Neil D, Willicombe M, Berry M, Roufosse C. Clinical-pathological correlations in post-transplant thrombotic microangiopathy. Histopathology. 2019 Jul; 75 (1):88-103
    View PubMed
  10. Schinstock CA, Bentall AJ, Smith BH, Cornell LD, Everly M, Gandhi MJ, Stegall MD. Long-term outcomes of eculizumab-treated positive crossmatch recipients: Allograft survival, histologic findings, and natural history of the donor-specific antibodies. Am J Transplant. 2019 Jun; 19 (6):1671-1683 Epub 2018 Dec 15
    View PubMed
  11. Dominic Heining, Senior Jonathan, Prasad Abheesh, Thomas Michael, Bentall A, Yates Phillip J.. Multi-system bleeding risk with a cutaneous angiosarcoma at an arteriovenous fistula site Oxford Medical Case Reports. 2018; 325-327.
  12. Bentall A, Amer H. Mitigating Risk of Immunosuppression by Immune Monitoring: Are We There? Transplantation 2018 Mar; 102 (3):349-350
    View PubMed
  13. Bentall A, R Barnett AN, Braitch M, Kessaris N, McKane W, Newstead C, McHaffie G, Brown A, Griffin S, Mamode N, Briggs D, Ball S. Clinical outcomes with ABO antibody titer variability in a multicenter study of ABO-incompatible kidney transplantation in the United Kingdom. Transfusion. 2016 Nov; 56: (11)2668-2679.
    View PubMed
  14. Gonzales MM, Bentall A, Kremers WK, Stegall MD, Borrows R. Predicting Individual Renal Allograft Outcomes Using Risk Models with 1-Year Surveillance Biopsy and Alloantibody Data. J Am Soc Nephrol. 2016 Oct; 27 (10):3165-3174 Epub 2016 Mar 09
    View PubMed
  15. Bentall A, Tyan DB, Sequeira F, Everly MJ, Gandhi MJ, Cornell LD, Li H, Henderson NA, Raghavaiah S, Winters JL, Dean PG, Stegall MD. Antibody-mediated rejection despite inhibition of terminal complement. Transpl Int. 2014 Dec; 27: (12)1235-43.
    View PubMed
  16. Bell C, Skordilis K, Al-Baaj F, Bentall A. Imported bugs, not beasts: extensively drug-resistant tuberculosis and acute kidney injury. Clin Kidney J. 2014 Dec; 7: (6)609-12.
    View PubMed
  17. Bentall A, Herrera LP, Cornell LD, Gonzales MA, Dean PG, Park WD, Gandhi MJ, Winters JL, Stegall MD. Differences in chronic intragraft inflammation between positive crossmatch and ABO-incompatible kidney transplantation. Transplantation. 2014 Nov 27; 98: (10)1089-96.
    View PubMed
  18. Hara H, Bentall A, Long C, Fang J, Andreyev O, Lunz J, Ezzelarab M, Abu-Elmagd KM, Shapiro R, Ayares D, Stegall M, Cooper DK. Minimal effect of bortezomib in reducing anti-pig antibodies in human leukocyte antigen-sensitized patients: a pilot study. Xenotransplantation. 2013 Nov-Dec; 20: (6)429-37.
    View PubMed
  19. Bentall A, Cornell LD, Gloor JM, Park WD, Gandhi MJ, Winters JL, Chedid MF, Dean PG, Stegall MD. Five-year outcomes in living donor kidney transplants with a positive crossmatch. Am J Transplant. 2013 Jan; 13: (1)76-85.
    View PubMed
  20. Nath J, McDaid J, Bentall A, Ball S, Ready AR, Inston NG. Sickle cell and renal transplant: a national survey and literature review. Exp Clin Transplant. 2012 Feb; 10: (1)1-7.
    View PubMed
  21. Smith HJ, Hanvesakul R, Bentall A, Shabir S, Morgan MD, Briggs D, Cockwell P, Borrows R, Larche M, Ball S. T Lymphocyte responses to nonpolymorphic HLA-derived peptides are associated with chronic renal allograft dysfunction. Transplantation. 2011 Feb 15; 91: (3)279-86.
    View PubMed
  22. Moore J, Shabir S, Chand S, Bentall A, McClean A, Chan W, Jham S, Benavente D, Sharif A, Ball S, Cockwell P, Borrows R. Assessing and comparing rival definitions of delayed renal allograft function for predicting subsequent graft failure. Transplantation. 2010 Nov 27; 90: (10)1113-6.
    View PubMed
  23. Smith HJ, Hanvesakul R, Morgan MD, Bentall A, Briggs D, Clark F, Pratt G, Moss P, Larche M, Ball S. Chronic graft versus host disease is associated with an immune response to autologous human leukocyte antigen-derived peptides. Transplantation. 2010 Sep 15; 90: (5)555-63.
    View PubMed
  24. Boos CJ, Bentall AJ, Marshall HJ. A technique to overcome high defibrillation thresholds for an implantable cardioverter defibrillator. Cardiol Young. 2009 Jun; 19: (3)291.
    View PubMed
PST-20340751